Skip to content

A Prospective Randomized Placebo Parallel-Controlled Clinical Study on the Effect of Xuanbai Chengqi Decoction in Accelerating the Recovery of Pulmonary and Gastrointestinal Functions after Colorectal Cancer Surgery

A Prospective Randomized Placebo Parallel-Controlled Clinical Study on the Effect of Xuanbai Chengqi Decoction in Accelerating the Recovery of Pulmonary and Gastrointestinal Functions after Colorectal Cancer Surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000787
Enrollment
Unknown
Registered
2025-04-18
Start date
2023-01-01
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

Control group:Placebo + Routine Post - operative Treatment
Experimental group:Xuanbai Chengqi Decoction + Routine Post - operative Treatment

Sponsors

Beijing Traditional Chinese Medicine Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Age range: 18 - 80 years old. (2) Clinically diagnosed with colorectal malignant tumor and planned to undergo surgical treatment in the near future. (3) No history of upper abdominal surgery. (4) Karnofsky Performance Status (KPS) > 60; Eastern Cooperative Oncology Group (ECOG) score: 0 - 2. (5) Life expectancy is more than 3 months and the patient is willing and able to comply with the study protocol during the research period.

Exclusion criteria

Exclusion criteria: (1) Patients with severe (i.e. active) underlying diseases clinically who are not expected to complete the surgery. (2) Patients who require immunosuppressive therapy due to organ transplantation. (3) Patients with severe uncontrolled recurrent infections or other severe uncontrolled concomitant diseases. (4) Detection of distant metastases during exploration. (5) Traditional Chinese medicines and traditional Chinese medicine therapies for promoting the recovery of gastrointestinal function after surgery.

Design outcomes

Primary

MeasureTime frame
Pulmonary function;Time of first exhaust;

Secondary

MeasureTime frame
Daily frequency of diarrhea;Daily gastric juice volume;Score of Gastrointestinal Dysfunction;Daily frequency of vomiting episodes;Daily frequency of nausea;Time for gastric tube removal;

Countries

China

Contacts

Public ContactMiao Yu

Beijing Traditional Chinese Medicine Hospital Affiliated to Capital Medical University

15210712026@163.com15210712026

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026